Clinical trial NCT06408740: Physical Activity Level in Psychosis Patients
Official title: The Effect of Physical Activity Level on Social Participation, Functioning and Quality of Life in Psychosis Patients
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Psychosis
Keywords: Psychosis
Social Participation
Functioning
Quality of Life
Physical Activity
Lead sponsor: Bandırma Onyedi Eylül University
Sponsor class: OTHER
First posted: 2024-05-10
Enrollment: 157
Sex: FEMALE
Minimum age (years): 20
Maximum age (years): 60
Standard ages: ADULT
Accepts healthy volunteers: no
Observational model: CASE_ONLY
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Psychosis patients

Brief summary: The aim of this study was to examine the effect of physical activity level on social participation, functioning and quality of life in patients with psychosis.

Detailed description: Positive and negative symptoms of schizophrenia will be assessed using the Positive and Negative Syndrome Scale, depression will be assessed using the Calgary Depression in Schizophrenia Scale, medication side effects will be assessed using the Glasgow Antipsychotic Side Effect Rating Scale, physical activity level will be assessed using the International Physical Activity Form, social participation will be assessed using the Social Participation Questionnaire, functioning will be assessed using the Brief Functioning Assessment Scale and quality of life will be assessed using the Nottingham Health Profile. The assessments are planned to last 30 minutes for each participant. Participants will be assessed only once and will not be reassessed.

Eligibility criteria: Inclusion Criteria:

* Patients diagnosed with schizophrenia and other psychotic disorders according to DSM-V criteria (brief psychosis disorder, schizophreniform disorder, schizoaffective disorder, other disorder with psychosis within the scope of another defined schizophrenia and other disorders with psychosis, other disorders with psychosis within the scope of undefined schizophrenia and other disorders with psychosis), who have had their first episode, who are receiving outpatient treatment
* Whose duration of illness is longer than 2 years
* Being between the ages of 18-65
* Being literate

Exclusion Criteria:

* The participant is in a period of active illness that makes it difficult to conduct research (Positive and Negative Syndrome Scale\>70 scale points, Calgary Depression in Schizophrenia Scale score \>11 scale points)
* Comorbid psychiatric illness
* The patient has an acute or chronic physical illness that impairs the general medical condition and a disease that will affect cognitive functions (neurological, neoplastic, endocrine and immune disorders, infection, epilepsy or any neurological disease, etc.).
* The patient has a physical illness (loss of limbs, paralysis, etc.) that requires additional care and causes significant disability
* Alcohol and substance use disorder

Primary outcomes:
measure: Positive and Negative Syndrome Scale
timeFrame: 6 months
measure: Calgary Schizophrenia Depression Scale
timeFrame: 6 months
measure: Glasgow Antipsychotic Side Effect Rating Scale
timeFrame: 6 months
measure: International Physical Activity Form
timeFrame: 6 months
measure: Community Participation Survey
timeFrame: 6 months
measure: Brief Functioning Assessment Scale
timeFrame: 6 months
measure: Nottingham Health Profile
timeFrame: 6 months
Secondary outcomes:
Other outcomes:
Locations:
city: Balıkesir
country: Turkey
facility: Bandırma Onyedi Eylül University
Study officials:
References: